Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND1 pseudogene 10 (MTND1P10) is a nuclear-encoded pseudogene derived from the mitochondrial MT-ND1 gene, which encodes NADH-ubiquinone oxidoreductase chain 1 (a core subunit of Complex I in the mitochondrial electron transport chain). Unlike the functional MT-ND1 gene, this pseudogene does not code for a protein and has no enzymatic or receptor activity. MTND1P10 is representative of nuclear mitochondrial pseudogenes (numts) that are remnants of historical mitochondrial DNA insertions into the nuclear genome, and current evidence does not support a direct biological or therapeutic role for MTND1P10. The majority of scientific and medical interest focuses on the functional MT-ND1 gene, whose mutations are associated with mitochondrial disorders such as Leber hereditary optic neuropathy and Leigh syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND1 pseudogene 10 (MTND1P10).